Sesquiterpenoids from Chloranthus Anhuiensis with Neuroprotective Effects in PC12 Cells.

Jian Xu,Hui-Lin Zhu,Jie Zhang,Tao Du,Er-Yan Guo,Wen-Yuan Liu,Jian-Guang Luo,Feng Ye,Feng,Wei Qu
DOI: https://doi.org/10.1021/acs.jnatprod.7b01076
IF: 5.1
2018-01-01
Journal of Natural Products
Abstract:Glutamate-induced excitotoxicity plays a vital role in neurodegenerative diseases. Neuroprotection against excitotoxicity has been considered as an effective experimental approach for preventing and/or treating excitotoxicity-mediated diseases. In the present study, six new sesquiterpenoids (1-6) and 26 known compounds of this type (7-32) were isolated and characterized from the whole plants of Chloranthus anhuiensis. Chlorantolide A (1) is the first example of a 5,6- seco-germacrane-type sesquiterpenoid, while phacadinane E (2) is a rare 4,5- seco-cadinane-type sesquiterpenoid. The structures of the new compounds were determined by spectroscopic analysis and by calculations of electronic circular dichroism (ECD) spectra. Their neuroprotective effects in mediating glutamate-induced PC12 cell apoptosis were evaluated. Compound 26 exhibited potent neuroprotective activity with an EC50 value of 3.3 ± 0.9 μM. Using Hoechst 33258 staining, a caspase-3 activity assay, and Western blot analysis it was demonstrated that this compound reduces the apoptosis of PC12 cells through inhibition of caspase-3 activity, while activating the Akt signaling pathway.
What problem does this paper attempt to address?